Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis

Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis

ObjectiveThe objective of this multicenter, observational, retrospective analysis was to evaluate the safety and efficacy of sacituzumab govitecan in metastatic triple-negative breast cancer (mTNBC) patients managed according to common clinical practice in Italy.MethodsData were retrieved by 7 sites...

Full description

Bibliographic Details
Main Authors: Roberta Caputo, Giuseppe Buono, Michela Piezzo, Claudia Martinelli, Daniela Cianniello, Alessandro Rizzo, Francesco Pantano, Nicoletta Staropoli, Rodolfo Cangiano, Salvatore Turano, Ida Paris, Francesco Nuzzo, Alessandra Fabi, Michelino De Laurentiis
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Oncology
Subjects:
Sacituzumab govitecan
triple negative
metastatic breast cancer
retrospective study
Italy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1362641/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1362641/full

Similar Items